Iliad Research & Trading L.P. 13D/13G Filings for CardioGenics Holdings Inc (CGNH)

Iliad Research & Trading L.P. 13D and 13G filings for CardioGenics Holdings Inc:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-02-26
11:25 am
Unchanged
2024-02-2613GCardioGenics Holdings Inc
CGNH
Iliad Research & Trading L.P.2,415,275
9.990%
0
(Unchanged)
Filing
2023-02-14
10:24 am
Unchanged
2023-02-1413GCardioGenics Holdings Inc
CGNH
Iliad Research & Trading L.P.2,415,275
9.990%
0
(Unchanged)
Filing
2022-02-07
4:51 pm
Unchanged
2022-02-0713GCardioGenics Holdings Inc
CGNH
Iliad Research & Trading L.P.2,415,275
9.990%
0
(Unchanged)
Filing
2021-01-22
2:43 pm
Unchanged
2021-01-2213GCardioGenics Holdings Inc
CGNH
Iliad Research & Trading L.P.2,415,275
9.990%
0
(Unchanged)
Filing